K-Dur 20 Extended-Release Tablets from Germany
Extended-release potassium chloride tablets (20 mEq) designed for once-daily dosing to prevent potassium deficiency in patients with diuretic-induced hypokalemia. Classified under HTS 3004.90.92.65 due to its mixed formulation primarily affecting electrolytic balance, packaged in retail blister packs. The controlled-release matrix ensures steady electrolyte replenishment.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include FDA registration and drug listing numbers; ensure NDC coding on packaging for seamless CBP clearance
• Document bioequivalence to US reference standards to prevent delays in therapeutic equivalence verification
• Avoid common error of insufficient stability data, critical for extended-release formulations during import inspection